Company / Current Assets per Share
Actinium Pharmaceuticals, Inc. Current Assets per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.58
FY2025
5-year range
$1.58 / $5.01
FY2021-FY2025
Trend
-41.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 3 consecutive years, from $5.01 in FY2022 to $1.58 in FY2025.
Based on SEC 10-K filings.
1.58 in FY2025 with a 3-year CAGR of -31.9%.
Declined from $3.05 to $1.58 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -31.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Actinium Pharmaceuticals, Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 41.3% year-over-year.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2011.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.58 | -41.3% |
| FY2024 | $2.70 | -11.6% |
| FY2023 | $3.05 | -39.2% |
| FY2022 | $5.01 | +10.1% |
| FY2021 | $4.55 | +718.5% |
| FY2011 | $0.56 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026